|
|
||||||||
AJP - Heart and Circulatory Physiology, Vol 266, Issue 4 1316-H1321, Copyright © 1994 by American Physiological Society
ARTICLES |
S. N. Jerome, M. Dore, J. C. Paulson, C. W. Smith and R. J. Korthuis
Department of Physiology, Louisiana State University Medical Center, School of Medicine in Shreveport 71130.
The aim of this study was to determine whether immunoneutralization of P-selectin or intercellular adhesion molecule-1 (ICAM-1) (endothelial cell adhesion molecules involved in leukocyte rolling and firm adhesion, respectively) would attenuate the development of postischemic capillary no-reflow. Microvascular patency was assessed in vascularly isolated canine gracilis muscles by perfusion with contrast media (India ink) at the end of the experimental protocol. Computerized video imaging was used to quantitate the number of ink-containing microvessels (< 10 microns diam) per muscle fiber in histological samples obtained from isolated canine gracilis muscles subjected to 4.5 h of continuous perfusion (nonischemic control), 4 h of ischemia and 30 min of reperfusion (I-R), I-R + P-selectin monoclonal antibodies (MAbs) (MD6 or PB1.3), and I-R + ICAM-1 MAbs (CL18/6C7 or R6.5). The efficacy of a P-selectin MAb (MD3) that binds to a nonfunctional epitope was also evaluated. I-R was associated with a marked reduction in the number of patent capillaries per fiber (3.1 +/- 0.2 vs. 1.1 +/- 0.2 patent capillaries/fiber for control and I-R, respectively). Immunoneutralization with MAbs directed against functional epitopes on P-selectin (MD6 or PB1.3) significantly improved capillary perfusion (2.3 +/- 0.3 and 3.6 +/- 0.6 patent capillaries/fiber, respectively). On the other hand, MAb MD3, which binds to nonfunctional epitopes on P-selectin, failed to limit the development of postischemic no-reflow (1.0 +/- 0.2 patent capillaries/fiber). Immunoneutralization of ICAM-1 with CL18/6C7 and R6.5 increased the number of patent capillaries per fiber to 1.8 +/- 0.1 and 2.5 +/- 0.3, respectively. These data indicate that P-selectin and ICAM-1-dependent adherence reactions play an important role in the development of the no-reflow phenomenon in postischemic skeletal muscle.
This article has been cited by other articles:
![]() |
N. C. Riedemann and P. A. Ward Complement in Ischemia Reperfusion Injury Am. J. Pathol., February 1, 2003; 162(2): 363 - 367. [Full Text] [PDF] |
||||
![]() |
P. Kubes, D. Payne, and R. C. Woodman Molecular mechanisms of leukocyte recruitment in postischemic liver microcirculation Am J Physiol Gastrointest Liver Physiol, July 1, 2002; 283(1): G139 - G147. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang, B. Zingarelli, and C. Szabo Crucial Role of Endogenous Interleukin-10 Production in Myocardial Ischemia/Reperfusion Injury Circulation, March 7, 2000; 101(9): 1019 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. O. Carter, C. Bull, E. Bortolon, L. Yang, G. J. Jesmok, and R. H. Gundel A murine skeletal muscle ischemia-reperfusion injury model: differential pathology in BALB/c and DBA/2N mice J Appl Physiol, November 1, 1998; 85(5): 1676 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Huang, M. Wu, C. Meininger, K. Kelly, and Y. Yuan Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1138 - H1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zingarelli, A. L. Salzman, and C. Szabo Genetic Disruption of Poly (ADP-Ribose) Synthetase Inhibits the Expression of P-Selectin and Intercellular Adhesion Molecule-1 in Myocardial Ischemia/Reperfusion Injury Circ. Res., July 13, 1998; 83(1): 85 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Harris, J. J. Costa, F. A. Delano, B. W. Zweifach, and G. W. Schmid-Schonbein Mechanisms of cell injury in rat mesentery and cremaster muscle Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H1009 - H1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Connolly Jr, C. J. Winfree, C. J. Prestigiacomo, S. C. Kim, T. F. Choudhri, B. L. Hoh, Y. Naka, R. A. Solomon, and D. J. Pinsky Exacerbation of Cerebral Injury in Mice That Express the P-Selectin Gene : Identification of P-Selectin Blockade as a New Target for the Treatment of Stroke Circ. Res., September 19, 1997; 81(3): 304 - 310. [Abstract] [Full Text] |
||||
![]() |
K. Fujise, B. M. Revelle, L. Stacy, E. L. Madison, E. T.H. Yeh, J. T. Willerson, and P. J. Beck A Tissue Plasminogen Activator/P-Selectin Fusion Protein Is an Effective Thrombolytic Agent Circulation, February 4, 1997; 95(3): 715 - 722. [Abstract] [Full Text] |
||||
![]() |
Y. Naka, K. Toda, K. Kayano, M. C. Oz, and D. J. Pinsky Failure to express the P-selectin gene or P-selectin blockade confers early pulmonary protection after lung ischemia or transplantation PNAS, January 21, 1997; 94(2): 757 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kanwar, B. Johnston, and P. Kubes Leukotriene C4/D4 Induces P-Selectin and Sialyl Lewisx–Dependent Alterations in Leukocyte Kinetics In Vivo Circ. Res., November 1, 1995; 77(5): 879 - 887. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |